XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Total United Natural Foods, Inc. Stockholders’ Equity
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Noncontrolling Interests
Beginning balance (in shares) at Jul. 30, 2022     58.9 0.6        
Beginning balance at Jul. 30, 2022 $ 1,792 $ 1,791 $ 1 $ (24) $ 608 $ (20) $ 1,226 $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     2.0          
Restricted stock vestings (39) (39)     (39)      
Share-based compensation 33 33     33      
Repurchases of common stock (in shares)       1.1        
Repurchases of common stock (41) (41)   $ (41)        
Other comprehensive income (loss) 5 5       5    
Distributions to noncontrolling interests (5)             (5)
Net (loss) income 97 92         92 5
Ending balance (in shares) at Apr. 29, 2023     60.9 1.7        
Ending balance at Apr. 29, 2023 1,842 1,841 $ 1 $ (65) 602 (15) 1,318 1
Beginning balance (in shares) at Jan. 28, 2023     60.9 1.3        
Beginning balance at Jan. 28, 2023 1,845 1,842 $ 1 $ (53) 592 (9) 1,311 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 10 10     10      
Repurchases of common stock (in shares)       0.4        
Repurchases of common stock (12) (12)   $ (12)        
Other comprehensive income (loss) (6) (6)       (6)    
Distributions to noncontrolling interests (3)             (3)
Net (loss) income 8 7         7 1
Ending balance (in shares) at Apr. 29, 2023     60.9 1.7        
Ending balance at Apr. 29, 2023 $ 1,842 1,841 $ 1 $ (65) 602 (15) 1,318 1
Beginning balance (in shares) at Jul. 29, 2023 58.5   61.0 2.5        
Beginning balance at Jul. 29, 2023 $ 1,744 1,743 $ 1 $ (86) 606 (28) 1,250 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     1.0          
Restricted stock vestings (6) (6)     (6)      
Share-based compensation 27 27     27      
Other comprehensive income (loss) (5) (5)       (5)    
Acquisition of noncontrolling interests (2) (3)     (3)     1
Distributions to noncontrolling interests (4)             (4)
Net (loss) income $ (73) (75)         (75) 2
Ending balance (in shares) at Apr. 27, 2024 59.5   62.0 2.5        
Ending balance at Apr. 27, 2024 $ 1,681 1,681 $ 1 $ (86) 624 (33) 1,175 0
Beginning balance (in shares) at Jan. 27, 2024     61.9 2.5        
Beginning balance at Jan. 27, 2024 1,692 1,692 $ 1 $ (86) 616 (35) 1,196 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Restricted stock vestings (in shares)     0.1          
Share-based compensation 11 11     11      
Other comprehensive income (loss) 2 2       2    
Acquisition of noncontrolling interests (2) (3)     (3)     1
Distributions to noncontrolling interests (2)             (2)
Net (loss) income $ (20) (21)         (21) 1
Ending balance (in shares) at Apr. 27, 2024 59.5   62.0 2.5        
Ending balance at Apr. 27, 2024 $ 1,681 $ 1,681 $ 1 $ (86) $ 624 $ (33) $ 1,175 $ 0